Liberum Capital reaffirmed their buy rating on shares of Cambian Group (LON:CMBN) in a report released on Wednesday morning. Liberum Capital currently has a GBX 232 ($3.12) target price on the health services provider’s stock.

Several other analysts have also recently issued reports on the company. J P Morgan Chase & Co increased their target price on Cambian Group from GBX 139 ($1.87) to GBX 153 ($2.06) and gave the stock a neutral rating in a research report on Tuesday, November 28th. Numis Securities cut Cambian Group to a hold rating and set a GBX 200 ($2.69) target price for the company. in a research report on Wednesday, September 20th.

Cambian Group (CMBN) traded down GBX 8 ($0.11) during trading hours on Wednesday, hitting GBX 160 ($2.15). The company had a trading volume of 1,078,293 shares, compared to its average volume of 566,542. Cambian Group has a 12-month low of GBX 115.25 ($1.55) and a 12-month high of GBX 237 ($3.19).

In other Cambian Group news, insider Mike Butterworth bought 5,750 shares of the business’s stock in a transaction that occurred on Monday, September 25th. The stock was purchased at an average price of GBX 201 ($2.71) per share, for a total transaction of £11,557.50 ($15,555.18).

ILLEGAL ACTIVITY NOTICE: “Cambian Group (CMBN) Earns Buy Rating from Liberum Capital” was posted by Watch List News and is owned by of Watch List News. If you are viewing this article on another domain, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark law. The correct version of this article can be accessed at https://www.watchlistnews.com/cambian-group-cmbn-earns-buy-rating-from-liberum-capital/1768026.html.

Cambian Group Company Profile

Cambian Group plc is a provider of specialist behavioral health services for children in the United Kingdom. The Company’s children services include specialist education services, specialist residential care services, foster care services and specialist mental health services. Its schools provide support to children with Autism, Asperger’s Syndrome, severe learning disabilities, challenging behavior and complex needs.

Receive News & Ratings for Cambian Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambian Group and related companies with MarketBeat.com's FREE daily email newsletter.